Westlake Chemical Partners LP filed a Form 8-K with the SEC on November 4, 2026, announcing the release of its third quarter 2026 financial results and an accompanying conference call held the same day.

Key Highlights

  • Filing date: The current report was filed and dated November 4, 2026, covering the event of that same date.
  • Results announced: Westlake Chemical Partners LP issued a press release on November 4, 2026, announcing its 2026 third quarter results, furnished as Exhibit 99.1.
  • Conference call: The Partnership held a conference call on November 4, 2026, to discuss its 2026 third quarter results, with details provided in the press release.
  • Items reported: The filing covers Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
  • Signing officer: The report was signed by Jean-Marc Gilson, President, Chief Executive Officer and Director, on behalf of Westlake Chemical Partners GP LLC.
  • Exchange listing: Common units representing limited partnership interests trade on NYSE:WLKP.

Westlake Chemical Partners Discloses Q3 2026 Earnings Filing Details

Westlake Chemical Partners LP, a Delaware limited partnership headquartered at 5444 Westheimer, Suite 101, Houston, Texas, filed a current report on November 4, 2026, pursuant to Item 2.02 of Form 8-K. According to the filing, the Partnership issued a press release on that date announcing its 2026 third quarter results, which was furnished as Exhibit 99.1 to the report. The filing notes that the information furnished, including Exhibit 99.1, "shall not be deemed to be 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended."

The filing also references Item 7.01, Regulation FD Disclosure, noting that the Partnership held a conference call on November 4, 2026, to discuss its 2026 third quarter results. The filing states that information about the call can be found in the press release furnished as Exhibit 99.1. No specific financial figures, revenue amounts, or earnings data were included in the body of the 8-K itself; those details are contained in the attached press release exhibit.

The report was signed by Jean-Marc Gilson, President, Chief Executive Officer and Director, acting on behalf of Westlake Chemical Partners GP LLC, the general partner of the registrant. The Commission File Number for the registrant is 001-36567, and its I.R.S. Employer Identification Number is 32-0436529.

What Was Disclosed

Westlake Chemical Partners LP filed an 8-K on November 4, 2026, to announce its third quarter 2026 earnings press release and a same-day conference call. The press release was furnished as Exhibit 99.1 and is not deemed "filed" under Section 18 of the Exchange Act.